Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Operating-Expenses" stands at 273.93 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of 64.73 Billion JPY for the item "Operating Expenses" represents a decrease of -8.32 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 64.73 Billion JPY for the item "Operating Expenses" represents a decrease of -1.92 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 273.93 Billion JPY for the item "Operating Expenses" represents a decrease of -0.46 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.81 percent compared to the value the year prior.
The 1 year change in percent is 12.81.
The 3 year change in percent is 29.61.
The 5 year change in percent is 55.79.
The 10 year change in percent is 55.36.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Expenses | 280,205,508,085.11 |